N-(3,4-Dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide,
139-76-4,
KDIKNBJFJOYFNY-UHFFFAOYSA-N,
N-(3,4-Dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl acetamide,
n-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxyphenylacetamide,
2-(3,4-Dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide,
2-(3,4-Dimethoxy-Phenyl)-N-(2-(3,4-Dimethoxy-Phenyl)-Ethyl)-Acetamide,
N-(2-(3,4-Dimethoxyphenyl)ethyl)-3,4-dimethoxyphenylacetamide,
N-(2-[3,4-Dimethoxyphenyl]ethyl)-3,4-dimethoxyphenylacetamide,
EINECS 205-374-0,
NSC140013,
AC1L27AO,
AC1Q5P5B,
Oprea1_835651,
MLS001048961,
SCHEMBL248400,
AC1Q46V4,
N-Homoveratroyl-homoveratrylamin,
CHEMBL1875355,
CTK0H7073,
DTXSID20160857,
HMS2270I10,
ZINC638975,
AKOS003629969,
MCULE-8511720985,
NSC-140013,
TRA0052501,
NCGC00246214-01,
SMR000386984,
AE-562/41718249,
I14-36569,
Benzeneacetamide,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-,
Acetamide,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-,
N-(3,4-Dimethoxyphenethyl)-3,4-dimethoxybenzeneacetamide,
N-(3,4-Dimethoxyphenethyl)-2-(4,5-dimethoxyphenyl)acetamide,
N-(3,4-dimethoxyphenylethyl)-2-(3,4-dimethoxyphenyl)acetamide,
Acetamide, N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-,
Benzeneacetamide, N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-,
2-(3,4-Dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide #,
Phenylacetic amide, N-[2-[3,4-dimethoxyphenyl]ethyl]-3,4-dimethoxy-,
C20H25NO5,
CID67318,
AR-1K3575,
C20-H25-N-O5,
Benzeneacetamide, N-(2-(3,4-dimethoxyphenyl)ethyl)-3,4-dimethoxy-,
19475-27-5,